Literature DB >> 26255889

Viruses and Gram-negative bacilli dominate the etiology of community-acquired pneumonia in Indonesia, a cohort study.

Helmia Farida1, M Hussein Gasem2, Agus Suryanto2, Monique Keuter3, Nasirun Zulkarnain4, Bambang Satoto4, Annemiek A van der Eijk5, R Djokomoeljanto2, Hendro Wahyono6, Henri A Verbrugh7, Juliëtte A Severin7, Peterhans J van den Broek8.   

Abstract

OBJECTIVE: Knowledge about the etiology of community-acquired pneumonia (CAP) is essential for adequate management. Presently, few studies about CAP are available from Southeast Asia. This study aimed to investigate the etiology, severity, and outcome of CAP in the most populous Southeast Asia country, Indonesia.
METHODS: From October 2007 to April 2009, adult patients admitted with CAP to two hospitals in Semarang, Indonesia, were included to detect the etiology of CAP using a full range of diagnostic methods. The severity of disease was classified according to the Pneumonia Severity Index (PSI). The outcome was assessed as 30-day mortality.
RESULTS: In total, 148 consecutive patients with CAP were included. Influenza virus (18%), Klebsiella pneumoniae (14%), and Streptococcus pneumoniae (13%) were the most common agents identified. Other Gram-negative bacilli, Mycobacterium tuberculosis, Chlamydia pneumoniae each accounted for 5%. The bacteria presented wild type antibiotic susceptibility profiles. Forty-four percent of subjects were high-risk patients (PSI class IV-V). The mortality rate (30%) was significantly associated with disease severity score (P<0.001), and with failure to establish an etiological diagnosis (P=0.027). No associations were found between etiology and underlying diseases, PSI class, nor mortality.
CONCLUSIONS: Viruses and Gram-negative bacilli are dominant causes of CAP in this region, more so than S. pneumoniae. Most of the bacteria have wild type susceptibility to antimicrobial agents. Patients with severe disease and those with unknown etiology have a higher mortality risk.
Copyright © 2015 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Asia; Community-aquired pneumonia; Etiology; Gram-negative bacilli; Tuberculosis; Virus

Mesh:

Year:  2015        PMID: 26255889      PMCID: PMC7110756          DOI: 10.1016/j.ijid.2015.07.023

Source DB:  PubMed          Journal:  Int J Infect Dis        ISSN: 1201-9712            Impact factor:   3.623


  23 in total

1.  Etiologies and treatment outcomes for out-patients with community-acquired pneumonia (CAP) at Srinagarind Hospital, Khon Kaen, Thailand.

Authors:  Wipa Reechaipichitkul; Viraphong Lulitanond; Kittisak Sawanyawisuth; Aroonlug Lulitanond; Panita Limpawattana
Journal:  Southeast Asian J Trop Med Public Health       Date:  2005-09       Impact factor: 0.267

2.  Evaluation of Culture Techniques for Isolation of Pseudomonas pseudomallei from Soil.

Authors:  L R Ashdown; S G Clarke
Journal:  Appl Environ Microbiol       Date:  1992-12       Impact factor: 4.792

3.  Faecal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae among humans in Java, Indonesia, in 2001-2002.

Authors:  Juliëtte A Severin; Endang Sri Lestari; Wendy Kloezen; Nicole Lemmens-den Toom; Ni Made Mertaniasih; Kuntaman Kuntaman; Marijam Purwanta; D Offra Duerink; Usman Hadi; Alex van Belkum; Henri A Verbrugh; Wil H Goessens
Journal:  Trop Med Int Health       Date:  2012-01-16       Impact factor: 2.622

4.  The use of multiplex real-time PCR improves the detection of the bacterial etiology of community acquired pneumonia.

Authors:  M I A Mustafa; F Al-Marzooq; S H How; Y C Kuan; T H Ng
Journal:  Trop Biomed       Date:  2011-12       Impact factor: 0.623

5.  Incidence of viral respiratory pathogens causing exacerbations in adult cystic fibrosis patients.

Authors:  Rogier A S Hoek; Marthe S Paats; Suzan D Pas; Marleen Bakker; Henk C Hoogsteden; Charles A B Boucher; Menno M van der Eerden
Journal:  Scand J Infect Dis       Date:  2012-09-19

6.  The etiology of community-acquired pneumonia in Australia: why penicillin plus doxycycline or a macrolide is the most appropriate therapy.

Authors:  Patrick G P Charles; Michael Whitby; Andrew J Fuller; Robert Stirling; Alistair A Wright; Tony M Korman; Peter W Holmes; Keryn J Christiansen; Grant W Waterer; Robert J P Pierce; Barrie C Mayall; John G Armstrong; Michael G Catton; Graeme R Nimmo; Barbara Johnson; Michelle Hooy; M L Grayson
Journal:  Clin Infect Dis       Date:  2008-05-15       Impact factor: 9.079

7.  Seasonal and temperature-associated increases in gram-negative bacterial bloodstream infections among hospitalized patients.

Authors:  Michael R Eber; Michelle Shardell; Marin L Schweizer; Ramanan Laxminarayan; Eli N Perencevich
Journal:  PLoS One       Date:  2011-09-26       Impact factor: 3.240

8.  Development and validation of a real-time PCR for detection of pathogenic leptospira species in clinical materials.

Authors:  Ahmed Ahmed; Mirjam F M Engelberts; Kimberly R Boer; Niyaz Ahmed; Rudy A Hartskeerl
Journal:  PLoS One       Date:  2009-09-18       Impact factor: 3.240

Review 9.  What is the role of respiratory viruses in community-acquired pneumonia?: What is the best therapy for influenza and other viral causes of community-acquired pneumonia?

Authors:  Andrew T Pavia
Journal:  Infect Dis Clin North Am       Date:  2012-12-12       Impact factor: 5.982

Review 10.  What is the role of newer molecular tests in the management of CAP?

Authors:  Charlotte A Gaydos
Journal:  Infect Dis Clin North Am       Date:  2013-03       Impact factor: 5.982

View more
  9 in total

Review 1.  Hypervirulent Klebsiella pneumoniae.

Authors:  Thomas A Russo; Candace M Marr
Journal:  Clin Microbiol Rev       Date:  2019-05-15       Impact factor: 26.132

2.  High frequency of Chlamydia pneumoniae and risk factors in children with acute respiratory infection.

Authors:  Matheus Silva Alves; Marilha da Silva Cariolano; Hivylla Lorrana Dos Santos Ferreira; Elen Sousa de Abreu Silva; Karen Karollynny Pereira Felipe; Silvio Gomes Monteiro; Eduardo Martins de Sousa; Afonso Gomes Abreu; Lee Ann Campbell; Michael E Rosenfeld; Mario Hiroyuki Hirata; Rosario Dominguez Crespo Hirata; Gisele Medeiros Bastos; Ilana Cristina de Paula Abreu Silva; Lidio Gonçalves Lima-Neto
Journal:  Braz J Microbiol       Date:  2020-01-30       Impact factor: 2.476

3.  Influenza virus infections among patients attending emergency department according to main reason to presenting to ED: A 3-year prospective observational study during seasonal epidemic periods.

Authors:  Enrique Casalino; Stephanie Antoniol; Nadhira Fidouh; Christophe Choquet; Jean-Christophe Lucet; Xavier Duval; Benoit Visseaux; Laurent Pereira
Journal:  PLoS One       Date:  2017-08-16       Impact factor: 3.240

4.  Etiological Trends and Patterns of Antimicrobial Resistance in Respiratory Infections.

Authors:  Salma M Al-Zain Ahmed; Sara S Abdelrahman; Doua M Saad; Isra S Osman; Modasir G Osman; Eltahir A G Khalil
Journal:  Open Microbiol J       Date:  2018-03-30

5.  An international perspective on hospitalized patients with viral community-acquired pneumonia.

Authors:  Dejan Radovanovic; Giovanni Sotgiu; Mateja Jankovic; Padukudru Anand Mahesh; Pedro Jorge Marcos; Mohamed I Abdalla; Marta Francesca Di Pasquale; Andrea Gramegna; Silvia Terraneo; Francesco Blasi; Pierachille Santus; Stefano Aliberti; Luis F Reyes; Marcos I Restrepo
Journal:  Eur J Intern Med       Date:  2018-11-04       Impact factor: 4.487

Review 6.  Systematic review of respiratory viral pathogens identified in adults with community-acquired pneumonia in Europe.

Authors:  Y Alimi; W S Lim; L Lansbury; J Leonardi-Bee; J S Nguyen-Van-Tam
Journal:  J Clin Virol       Date:  2017-08-05       Impact factor: 3.168

7.  Multidrug-Resistant Infections Among Hospitalized Adults With Community-Acquired Pneumonia In An Indonesian Tertiary Referral Hospital.

Authors:  Abdul Kr Purba; Purwantyastuti Ascobat; Armen Muchtar; Laksmi Wulandari; Alfian Nur Rosyid; Priyo Budi Purwono; Tjip S van der Werf; Alex W Friedrich; Maarten J Postma
Journal:  Infect Drug Resist       Date:  2019-11-25       Impact factor: 4.003

8.  Identification of Mycoplasma pneumoniae-associated pneumonia cases among hospitalized patients using CLART® microarray technology.

Authors:  Enty Tjoa; Shikha Joon; Lucky Hartati Moehario; Luse Loe; Franz J V Pangalila
Journal:  J Int Med Res       Date:  2022-09       Impact factor: 1.573

Review 9.  Community-Acquired Pneumonia in the Asia-Pacific Region.

Authors:  Jae-Hoon Song; Kyungmin Huh; Doo Ryeon Chung
Journal:  Semin Respir Crit Care Med       Date:  2016-12-13       Impact factor: 3.119

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.